Dr Beg also conducts trials for new cancer treatments and co-leads the Gastrointestinal Cancers Disease Oriented Team at Simmons Cancer Center. He is a member of the ECOG-ACRIN Cancer Research Group's Gastrointestinal Cancer Core Committee, where he leads the Pancreatic-Hepatobiliary Cancers working group. He is also a member of the National Cancer Institute (NCI) GI Cancer Steering Committee's Pancreatic Cancer task force. Additionally, he is leading multiple trials on drug combinations in our labs at UT Southwestern, which have been found to have promise.